乙醇胺作为一种有效的治疗在自身免疫性脑炎的pilomotor发作
Kia Gilani1, Apameh Tarazi1, Richard Wennberg1
1Division of Neurology, Department of Medicine, Krembil Brain Institute, University Health Network, University of Toronto, Toronto, Canada.
Epilepsia
|March 27, 2024
概括
乙胺有效地治疗自身免疫性脑炎 (AE) 中的螺旋运动发作,特别是抗LGI1脑炎. 乙胺的循环疗法显著降低了AE相关的发作患者的发作频率.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 药理学 药理学 是一个学科.
背景情况:
- 螺旋发作经常与自身免疫性脑炎 (AE),特别是抗LGI1脑炎有关.
- 碳酸胺酶抑制剂,如乙醇胺,显示出治疗AE相关的脚运动发作的潜力.
研究的目的:
- 评估阿西塔佐胺在治疗自身免疫性脑炎患者的发作发作的疗效.
- 评估循环阿西塔佐拉米德治疗方案在预防症耐受性方面的有效性.
主要方法:
- 六名患有AE和pilomotor发作的患者接受了循环乙胺治疗方案 (2天-ON,4天-OFF).
- 发作频率通过监测单元 (EMU) 的记录和门诊发作日记进行监测.
- 数据分析包括乙胺使用与发作比例之间的相关性,并比较服用药物和停药期间的发作率.
主要成果:
- 一份详细的发作日记显示,乙醇胺的使用与每日发作频率之间存在反向相关性.
- 在EMU中的患者在服用乙胺时,每天的发作显著减少,与休息期间相比 (0.56vs3.81次/天,p=0.004).
- 门诊患者报告了发作频率的大幅降低,其中一名患者没有发作.
结论:
- 乙醇胺在控制与自身免疫性脑炎相关的脚发作方面表现出显著的有效性.
- 循环疗法可能有助于减轻耐受性,这表明乙胺在慢性或急性管理中的实用性.
- 大脑的CO2/pH敏感性是阿扎胺在这种患者群体中有效性的可能机制.
相关概念视频
01:20Antiepileptic Drugs: Potassium Channel Activators
180
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
180
01:14Antiepileptic Drugs: Glutamate Antagonists
338
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
338
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
389
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
389
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
288
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
288
01:17Antiepileptic Drugs: Calcium Channel Blockers
385
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
385
01:08Antiepileptic Drugs: Sodium Channel Blockers
530
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
530